Established as an anti-cancer drug development company
Started engaging in activities as a CRO / CDMO in Taiwan and the United States
Exclusive agency contract with MBI
|Commenced Licensing business
|Served as Secretariat of Japan Pharmaceutical Licensing Association (volunteer)
|Entered into Licensing business alliance with ADM Korea Inc.